Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

Overview of attention for article published in British Journal of Cancer, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 14 news outlets
twitter: 37 X users

reddit: 1 Redditor

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Reddit Dimensions citations

So far, Altmetric has seen 39 X posts from 37 X users, with an upper bound of 131,992 followers.

Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150 | British Journal of Cancer https://t.co/K8VKvBCjN5

27 Nov 2021

Reply Repost Favourite

PPI use is associated with worse survival in patients with advanced cancer treated with atezolizumab plus chemotherapy https://t.co/UN9NjTa3Lb

24 Nov 2021

Reply Repost Favourite

RT @farma_gregorio: A vueltas con los IBPs…En un análisis post Hoc del IMpower150 se observa que el uso de IBP se asocia con peores SG y SL…

23 Nov 2021

Reply Repost Favourite

RT @farma_gregorio: A vueltas con los IBPs…En un análisis post Hoc del IMpower150 se observa que el uso de IBP se asocia con peores SG y SL…

23 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 35 additional X posts.